|
Short-term exposure to NAP |
|
Previtellogenic stage |
Vitelloginic stage |
|
Tel |
Hypo |
Pitu |
PO |
Tel |
Hypo |
Pitu |
PO |
5-HT |
C |
572.96 ± 66.53 |
1834.02 ± 21.81 |
55.77 ± 4.25 |
295.34 ± 3.1 |
491.33 ± 1.85 |
1351.66 ± 15.89 |
24.01 ± 0.55 |
238.78 ± 2.14 |
E |
1108.36 ± 3.22↑ |
1964.33 ± 9.79↑ |
46.73 ± 1.82↓ |
305.08 ± 3.62 |
650.44 ± 5.88↑ |
1391.86 ± 4.32 |
22.51 ± 0.64 |
242.40 ± 3.06 |
5-HIAA |
C |
368.6 ± 5.16 |
190.34 ± 3.17 |
41.16 ± 3.49 |
86.61 ± 2.40 |
212.43 ± 1.82 |
123.84 ± 4.38 |
7.91 ± 0.42 |
54.71 ± 2.21 |
E |
334.5 ± 5.16↓ |
163.13 ± 2.37↓ |
28.13 ± 1.27↓ |
56.35 ± 2.06↓ |
217.92 ± 1.11 |
127.53 ± 0.26 |
9.86 ± 0.12 |
48.38 ± 1.45 |
DA |
C |
185.53 ± 2.41 |
1645.89 ± 55.02 |
293.24 ± 3.56 |
145.87 ± 8.35 |
107.97 ± 1.93 |
996.95 ± 1.76 |
207.27 ± 1.70 |
112.33 ± 1.45 |
E |
218.72 ± 1.15↑ |
1763.96 ± 218.65 |
304.61 ± 7.99 |
183.13 ± 2.83↑ |
132.34 ± 19.63 |
1002.28 ± 0.68 |
190.22 ± 5.82 |
117.03 ± 1.06 |
DOPAC |
C |
11.66 ± 0.44 |
11.10 ± 0.46 |
34.77 ± 2.48 |
6.17 ± 0.72 |
6.56 ± 0.47 |
5.73 ± 0.28 |
13.07 ± 1.21 |
2.01 ± 0.04 |
E |
14.20 ± 1.69 |
12.46 ± 0.75 |
31.86 ± 2.87 |
4.23 ± 0.21↑ |
6.93 ± 0.23 |
6.66 ± 3.69 |
8.68 ± 0.77 |
2.23 ± 0.13 |
NA |
C |
679.18 ± 5.52 |
678.69 ± 5.73 |
101.12 ± 1.53 |
230.73 ± 2.30 |
604.56 ± 2.73 |
614.33 ± 2.96 |
73.76 ± 2.13 |
198.56 ± 0.78 |
E |
753.53 ± 97.70 |
695.82 ± 3.22↑ |
82.28 ± 1.54↓ |
229.83 ± 2.08 |
593.03 ± 3.02 |
607.13 ± 1.04 |
67.94 ± 2.96 |
193.21 ± 1.59 |
Tel = Telencephalon, Hypo = Hypothalamus, Pitu = Hypophysis, PO = Preoptic area
5-HT= Serotonine, 5-HIAA= 5-hydroxy-3-indoleacetic acid, DA = Dopamine, DOPAC= 3,4-dihydroxyphenylacetic acid, NA. = Noradrenalin, C= Control, E= Exposed whit
NAP ↑ significantly increased in compare with control, ↓ significantly decreased in compare with control, |